US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Savara Inc

5.53

-0.1900-3.32%

Post-market: 5.640.1122+2.03%19:53 EST

Volume:1.02M

Turnover:5.69M

Market Cap:1.13B

PE:-10.34

High:5.74

Open:5.67

Low:5.49

Close:5.72

52wk High:7.01

52wk Low:1.89

Shares:203.47M

Float Shares:115.00M

Volume Ratio:0.63

T/O Rate:0.89%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5350

EPS(LYR):-0.4838

ROE:-78.74%

ROA:-39.67%

PB:11.92

PE(LYR):-11.43

Loading ...

Overview Company News Filings

Stocks to Watch: iPower, Savara

Savara Inc. Publishes Corporate Presentation on Autoimmune PAP and MOLBREEVI (Molgramostim) Program

FDA accepts Savara’s MOLBREEVI BLA for priority review in autoimmune PAP

Savara Inc - to Submit Molbreevi MAAS to Ema and Mhra by Q1 2026

THOMSON REUTERS

Savara Announces the U.S. Food and Drug Administration (FDA) Filed the Molbreevi* Biologics License Application (Bla) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune Pap)

THOMSON REUTERS

Savara Inc - FDA Grants Priority Review, Pdufa Date August 22, 2026

THOMSON REUTERS

A Look At Savara (SVRA) Valuation After Recent FDA Progress And Strengthened Outlook

Simply Wall St.

Savara Inc. Grants Equity Awards to New Employee

Savara Inc. nimmt an bevorstehenden Investor Healthcare Conferences teil

Savara Inc. Highlights Leadership Team and Progress on MOLBREEVI for Autoimmune PAP in New Presentation

Savara Secures Up to $75 Million in Additional Debt Funding from Hercules Capital Pending FDA Approval of MOLBREEVI

Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of Molbreevi*

THOMSON REUTERS

Assessing Savara (SVRA) Valuation As Legal Scrutiny Over MOLBREEVI Disclosures Intensifies

Simply Wall St.

DIARY-India economic, corporate events on January 20

Savara Grants Stock Options and RSUs to New Employees

What Savara (SVRA)'s Exclusive PANTHERx MOLBREEVI Distribution Deal Means For Shareholders

Simply Wall St.

Savara (SVRA): Advancing MOLBREEVI Toward Likely FDA Approval and Blockbuster Rare Disease Potential

Savara Submits MOLBREEVI BLA to FDA for Autoimmune PAP Treatment

Savara Inc : H.c. Wainwright Raises Target Price to $10

THOMSON REUTERS

How Investors May Respond To Savara (SVRA) Joining S&P Biotech Index After Key MOLBREEVI Patent Win

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SVRA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SVRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVRA\",,,,,undefined,":{"symbol":"SVRA","market":"US","secType":"STK","nameCN":"Savara Inc","latestPrice":5.53,"timestamp":1771621200000,"preClose":5.72,"halted":0,"volume":1022536,"hourTrading":{"tag":"盘后","latestPrice":5.6422,"preClose":5.53,"latestTime":"19:53 EST","volume":69808,"amount":394291.113,"timestamp":1771635208593,"change":0.1122,"changeRate":0.020289,"amplitude":0.099458},"delay":0,"changeRate":-0.03321678321678313,"floatShares":114999999,"shares":203467845,"eps":-0.535012,"marketStatus":"Market Closed","change":-0.19,"latestTime":"02-20 16:00:00 EST","open":5.67,"high":5.74,"low":5.485,"amount":5691475.254904,"amplitude":0.04458,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.535012,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":5.72,"preHourTrading":{"tag":"盘前","latestPrice":5.8,"preClose":5.72,"latestTime":"09:00 EST","volume":66,"amount":377.930025,"timestamp":1771596023898,"change":0.08,"changeRate":0.013986,"amplitude":0.08042},"postHourTrading":{"tag":"盘后","latestPrice":5.6422,"preClose":5.53,"latestTime":"19:53 EST","volume":69808,"amount":394291.113,"timestamp":1771635208593,"change":0.1122,"changeRate":0.020289,"amplitude":0.099458},"volumeRatio":0.6315161994339411,"impliedVol":1.1041,"impliedVolPercentile":0.6175},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SVRA\",,,,,undefined,":{"symbol":"SVRA","floatShares":114999999,"roa":"-39.67%","roe":"-78.74%","lyrEps":-0.483778,"volumeRatio":0.6315161994339411,"shares":203467845,"dividePrice":0,"high":5.74,"amplitude":0.04458,"preClose":5.72,"low":5.485,"week52Low":1.89,"pbRate":"11.92","week52High":7.005,"institutionHeld":0.7736,"latestPrice":5.53,"eps":-0.535012,"divideRate":0,"volume":1022536,"delay":0,"ttmEps":-0.535012,"open":5.67,"prevYearClose":6.03,"prevWeekClose":5.6,"prevMonthClose":5.4,"prevQuarterClose":6.03,"fiveDayClose":5.83,"twentyDayClose":6.46,"sixtyDayClose":4.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SVRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"SVRA","fiscalQuarterEnding":"2025/09","expectedEps":-0.13,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2025-08-13","symbol":"SVRA","fiscalQuarterEnding":"2025/06","expectedEps":-0.12,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-05-13","symbol":"SVRA","fiscalQuarterEnding":"2025/03","expectedEps":-0.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2025-03-27","symbol":"SVRA","fiscalQuarterEnding":"2024/12","expectedEps":-0.11,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2024-11-12","symbol":"SVRA","fiscalQuarterEnding":"2024/09","expectedEps":-0.11,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SVRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SVRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1760418000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SVRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SVRA","date":"2026-02-20","current":-10.336217,"percent":0.084484,"low":-15.250395,"twenty":-10.788754,"median":-6.304726,"eighty":-3.59261,"high":-1.305613,"avg":-6.902488,"sd":3.372792,"marketCap":1413356064},"quantilePoints":[{"date":"2021-02-26","current":-1.361682,"twenty":-12.891273,"median":-4.62988,"eighty":-1.350118,"marketCap":92040167},{"date":"2021-03-05","current":-1.305613,"twenty":-12.863376,"median":-4.621344,"eighty":-1.350118,"marketCap":88250278},{"date":"2021-03-12","current":-3.165054,"twenty":-12.829476,"median":-4.612647,"eighty":-1.350118,"marketCap":157034153},{"date":"2021-03-19","current":-4.660928,"twenty":-12.812954,"median":-4.617041,"eighty":-1.352442,"marketCap":231251921},{"date":"2021-03-26","current":-3.715232,"twenty":-12.757012,"median":-4.60597,"eighty":-1.356784,"marketCap":184331241},{"date":"2021-04-01","current":-5.066226,"twenty":-12.741178,"median":-4.60597,"eighty":-1.358646,"marketCap":251360784},{"date":"2021-04-09","current":-4.390729,"twenty":-12.710729,"median":-4.602916,"eighty":-1.360692,"marketCap":217846012},{"date":"2021-04-16","current":-4.0061,"twenty":-12.689186,"median":-4.593753,"eighty":-1.363198,"marketCap":198762644},{"date":"2021-04-23","current":-4.532616,"twenty":-12.680931,"median":-4.581348,"eighty":-1.365468,"marketCap":224885734},{"date":"2021-04-30","current":-4.34948,"twenty":-12.67106,"median":-4.569318,"eighty":-1.368891,"marketCap":215799442},{"date":"2021-05-07","current":-3.731396,"twenty":-12.659433,"median":-4.547937,"eighty":-1.372741,"marketCap":185133206},{"date":"2021-05-14","current":-3.991883,"twenty":-12.647687,"median":-4.538775,"eighty":-1.376285,"marketCap":177283502},{"date":"2021-05-21","current":-4.375718,"twenty":-12.629678,"median":-4.535319,"eighty":-1.377702,"marketCap":194329993},{"date":"2021-05-28","current":-4.606018,"twenty":-12.607087,"median":-4.537972,"eighty":-1.377702,"marketCap":204557887},{"date":"2021-06-04","current":-4.631607,"twenty":-12.584711,"median":-4.538775,"eighty":-1.377702,"marketCap":205694320},{"date":"2021-06-11","current":-4.682785,"twenty":-12.532821,"median":-4.547937,"eighty":-1.378108,"marketCap":207967185},{"date":"2021-06-18","current":-4.529252,"twenty":-12.472192,"median":-4.554841,"eighty":-1.378717,"marketCap":201148589},{"date":"2021-06-25","current":-4.529252,"twenty":-12.452064,"median":-4.547937,"eighty":-1.378717,"marketCap":201148589},{"date":"2021-07-02","current":-4.06865,"twenty":-12.447278,"median":-4.538775,"eighty":-1.381515,"marketCap":180692800},{"date":"2021-07-09","current":-3.896613,"twenty":-12.425835,"median":-4.537972,"eighty":-1.385712,"marketCap":173052477},{"date":"2021-07-16","current":-3.486443,"twenty":-12.36154,"median":-4.530934,"eighty":-1.385712,"marketCap":154836427},{"date":"2021-07-23","current":-3.409536,"twenty":-12.350175,"median":-4.526557,"eighty":-1.387816,"marketCap":151420917},{"date":"2021-07-30","current":-3.281358,"twenty":-12.321729,"median":-4.520448,"eighty":-1.396232,"marketCap":145728401},{"date":"2021-08-06","current":-3.230087,"twenty":-12.231582,"median":-4.514995,"eighty":-1.396631,"marketCap":143451395},{"date":"2021-08-13","current":-2.947628,"twenty":-11.975524,"median":-4.505177,"eighty":-1.398928,"marketCap":135478860},{"date":"2021-08-20","current":-3.071478,"twenty":-11.799285,"median":-4.496014,"eighty":-1.403193,"marketCap":141171249},{"date":"2021-08-27","current":-3.542107,"twenty":-11.689386,"median":-4.462032,"eighty":-1.409182,"marketCap":162802328},{"date":"2021-09-03","current":-3.839347,"twenty":-11.217586,"median":-4.410492,"eighty":-1.410882,"marketCap":176464062},{"date":"2021-09-10","current":-3.591647,"twenty":-10.802353,"median":-4.401307,"eighty":-1.415446,"marketCap":165079283},{"date":"2021-09-17","current":-3.443027,"twenty":-10.699669,"median":-4.3851,"eighty":-1.417737,"marketCap":158248416},{"date":"2021-09-24","current":-3.220097,"twenty":-10.679132,"median":-4.375718,"eighty":-1.417751,"marketCap":148002116},{"date":"2021-10-01","current":-3.319177,"twenty":-10.442959,"median":-4.367971,"eighty":-1.417751,"marketCap":152556027},{"date":"2021-10-08","current":-3.294407,"twenty":-10.432691,"median":-4.350129,"eighty":-1.430744,"marketCap":151417550},{"date":"2021-10-15","current":-3.195327,"twenty":-10.391617,"median":-4.34948,"eighty":-1.433771,"marketCap":146863638},{"date":"2021-10-22","current":-2.997168,"twenty":-10.330007,"median":-4.326588,"eighty":-1.433771,"marketCap":137755816},{"date":"2021-10-29","current":-2.873318,"twenty":-10.330007,"median":-4.278431,"eighty":-1.441065,"marketCap":132063427},{"date":"2021-11-05","current":-2.972398,"twenty":-10.206786,"median":-4.233525,"eighty":-1.441781,"marketCap":136617338},{"date":"2021-11-12","current":-2.831373,"twenty":-10.199059,"median":-4.210516,"eighty":-1.441781,"marketCap":128671754},{"date":"2021-11-19","current":-2.706091,"twenty":-10.024453,"median":-4.202795,"eighty":-1.441781,"marketCap":122978313},{"date":"2021-11-26","current":-2.881486,"twenty":-9.917635,"median":-4.190578,"eighty":-1.443357,"marketCap":130949130},{"date":"2021-12-03","current":-2.655978,"twenty":-9.874496,"median":-4.159412,"eighty":-1.454242,"marketCap":120700937},{"date":"2021-12-10","current":-2.605866,"twenty":-9.788221,"median":-4.129491,"eighty":-1.457614,"marketCap":118423561},{"date":"2021-12-17","current":-2.956655,"twenty":-9.743029,"median":-4.105056,"eighty":-1.462169,"marketCap":134365194},{"date":"2021-12-23","current":-3.232276,"twenty":-9.69989,"median":-4.096593,"eighty":-1.463261,"marketCap":146890763},{"date":"2021-12-31","current":-3.106994,"twenty":-9.673793,"median":-4.05298,"eighty":-1.463326,"marketCap":141197323},{"date":"2022-01-07","current":-3.282388,"twenty":-9.655788,"median":-4.006708,"eighty":-1.46638,"marketCap":149168139},{"date":"2022-01-14","current":-3.257332,"twenty":-9.570476,"median":-3.985431,"eighty":-1.469278,"marketCap":148029451},{"date":"2022-01-21","current":-2.881486,"twenty":-9.517068,"median":-3.938427,"eighty":-1.471159,"marketCap":130949130},{"date":"2022-01-28","current":-2.85643,"twenty":-9.509957,"median":-3.909431,"eighty":-1.473381,"marketCap":129810442},{"date":"2022-02-04","current":-3.081937,"twenty":-9.504428,"median":-3.896613,"eighty":-1.474842,"marketCap":140058635},{"date":"2022-02-11","current":-3.006768,"twenty":-9.486889,"median":-3.881309,"eighty":-1.476376,"marketCap":136642570},{"date":"2022-02-18","current":-2.78126,"twenty":-9.460663,"median":-3.84849,"eighty":-1.477623,"marketCap":126394377},{"date":"2022-02-25","current":-2.756204,"twenty":-9.445342,"median":-3.839347,"eighty":-1.479961,"marketCap":125255689},{"date":"2022-03-04","current":-2.756204,"twenty":-9.43811,"median":-3.808811,"eighty":-1.482282,"marketCap":125255689},{"date":"2022-03-11","current":-2.706091,"twenty":-9.431308,"median":-3.768435,"eighty":-1.484092,"marketCap":122978313},{"date":"2022-03-18","current":-3.257332,"twenty":-9.410249,"median":-3.731396,"eighty":-1.486429,"marketCap":148029451},{"date":"2022-03-25","current":-3.081937,"twenty":-9.366646,"median":-3.708504,"eighty":-1.4958,"marketCap":140058635},{"date":"2022-04-01","current":-3.499619,"twenty":-9.311844,"median":-3.597148,"eighty":-1.497733,"marketCap":150532615},{"date":"2022-04-08","current":-3.499619,"twenty":-9.262945,"median":-3.56335,"eighty":-1.505113,"marketCap":150532615},{"date":"2022-04-14","current":-3.340545,"twenty":-9.257117,"median":-3.542107,"eighty":-1.505113,"marketCap":143690223},{"date":"2022-04-22","current":-3.261009,"twenty":-9.233589,"median":-3.521352,"eighty":-1.505113,"marketCap":140269027},{"date":"2022-04-29","current":-3.128447,"twenty":-9.200262,"median":-3.499619,"eighty":-1.510539,"marketCap":134567034},{"date":"2022-05-06","current":-3.048911,"twenty":-9.104739,"median":-3.444811,"eighty":-1.510539,"marketCap":131145839},{"date":"2022-05-13","current":-3.468662,"twenty":-9.032946,"median":-3.420082,"eighty":-1.510539,"marketCap":142551588},{"date":"2022-05-20","current":-3.801653,"twenty":-8.916829,"median":-3.420082,"eighty":-1.510539,"marketCap":156236541},{"date":"2022-05-27","current":-3.662907,"twenty":-8.862364,"median":-3.420082,"eighty":-1.510539,"marketCap":150534477},{"date":"2022-06-03","current":-3.746155,"twenty":-8.73459,"median":-3.420082,"eighty":-1.510539,"marketCap":153955715},{"date":"2022-06-10","current":-3.91265,"twenty":-8.186259,"median":-3.420082,"eighty":-1.510539,"marketCap":160798192},{"date":"2022-06-17","current":-3.607408,"twenty":-7.972847,"median":-3.420082,"eighty":-1.510539,"marketCap":148253652},{"date":"2022-06-24","current":-4.356639,"twenty":-7.810479,"median":-3.420082,"eighty":-1.509183,"marketCap":179044795},{"date":"2022-07-01","current":-4.273391,"twenty":-7.710825,"median":-3.420082,"eighty":-1.509183,"marketCap":175623557},{"date":"2022-07-08","current":-5.161369,"twenty":-7.620641,"median":-3.420082,"eighty":-1.509183,"marketCap":212116764},{"date":"2022-07-15","current":-4.939374,"twenty":-7.600302,"median":-3.420082,"eighty":-1.509183,"marketCap":202993462},{"date":"2022-07-22","current":-4.967124,"twenty":-7.582154,"median":-3.420082,"eighty":-1.509183,"marketCap":204133875},{"date":"2022-07-29","current":-4.495386,"twenty":-7.569092,"median":-3.420082,"eighty":-1.509183,"marketCap":184746859},{"date":"2022-08-05","current":-4.828377,"twenty":-7.552842,"median":-3.420082,"eighty":-1.509183,"marketCap":198431811},{"date":"2022-08-12","current":-4.959637,"twenty":-7.50861,"median":-3.420082,"eighty":-1.509183,"marketCap":195012917},{"date":"2022-08-19","current":-4.785614,"twenty":-7.441671,"median":-3.420082,"eighty":-1.509183,"marketCap":188170359},{"date":"2022-08-26","current":-4.147533,"twenty":-7.384548,"median":-3.420082,"eighty":-1.509183,"marketCap":163080978},{"date":"2022-09-02","current":-4.20554,"twenty":-7.353882,"median":-3.420082,"eighty":-1.509183,"marketCap":165361830},{"date":"2022-09-09","current":-4.292551,"twenty":-7.292493,"median":-3.420082,"eighty":-1.509183,"marketCap":168783110},{"date":"2022-09-16","current":-4.350559,"twenty":-7.23411,"median":-3.420082,"eighty":-1.509183,"marketCap":171063963},{"date":"2022-09-23","current":-4.118529,"twenty":-7.185667,"median":-3.420082,"eighty":-1.509183,"marketCap":161940551},{"date":"2022-09-30","current":-4.495577,"twenty":-7.131131,"median":-3.420082,"eighty":-1.509183,"marketCap":176766095},{"date":"2022-10-07","current":-3.799488,"twenty":-6.953497,"median":-3.420082,"eighty":-1.509183,"marketCap":149395861},{"date":"2022-10-14","current":-3.538454,"twenty":-6.76637,"median":-3.420082,"eighty":-1.509183,"marketCap":139132023},{"date":"2022-10-21","current":-3.567458,"twenty":-6.674372,"median":-3.418257,"eighty":-1.509183,"marketCap":140272449},{"date":"2022-10-28","current":-3.596462,"twenty":-6.528013,"median":-3.409536,"eighty":-1.509183,"marketCap":141412876},{"date":"2022-11-04","current":-3.306424,"twenty":-6.435942,"median":-3.39357,"eighty":-1.509183,"marketCap":130008611},{"date":"2022-11-11","current":-3.407341,"twenty":-6.335605,"median":-3.393436,"eighty":-1.509183,"marketCap":133431481},{"date":"2022-11-18","current":-3.989793,"twenty":-6.251734,"median":-3.393436,"eighty":-1.509183,"marketCap":156240281},{"date":"2022-11-25","current":-4.193651,"twenty":-6.184618,"median":-3.393436,"eighty":-1.509183,"marketCap":164223361},{"date":"2022-12-02","current":-4.717857,"twenty":-6.013388,"median":-3.393436,"eighty":-1.509183,"marketCap":184751281},{"date":"2022-12-09","current":-4.601367,"twenty":-5.8031,"median":-3.393436,"eighty":-1.509183,"marketCap":180189521},{"date":"2022-12-16","current":-4.426631,"twenty":-5.727576,"median":-3.393436,"eighty":-1.509183,"marketCap":173346881},{"date":"2022-12-23","current":-4.368386,"twenty":-5.610336,"median":-3.393436,"eighty":-1.509183,"marketCap":171066001},{"date":"2022-12-30","current":-4.513999,"twenty":-5.561222,"median":-3.393436,"eighty":-1.509183,"marketCap":176768201},{"date":"2023-01-06","current":-5.067328,"twenty":-5.484318,"median":-3.393436,"eighty":-1.509183,"marketCap":198436561},{"date":"2023-01-13","current":-5.329431,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":208700521},{"date":"2023-01-20","current":-6.086618,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":238351962},{"date":"2023-01-27","current":-8.008708,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":313621002},{"date":"2023-02-03","current":-6.872928,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":269143842},{"date":"2023-02-10","current":-7.105908,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":278267362},{"date":"2023-02-17","current":-8.008708,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":313621002},{"date":"2023-02-24","current":-7.368011,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":288531322},{"date":"2023-03-03","current":-6.90205,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":270284282},{"date":"2023-03-10","current":-6.144863,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":240632842},{"date":"2023-03-17","current":-5.911883,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":231509322},{"date":"2023-03-24","current":-5.824515,"twenty":-5.418781,"median":-3.393436,"eighty":-1.509183,"marketCap":228088002},{"date":"2023-03-31","current":-5.830308,"twenty":-5.430741,"median":-3.393436,"eighty":-1.510539,"marketCap":222426235},{"date":"2023-04-06","current":-5.052933,"twenty":-5.408841,"median":-3.393436,"eighty":-1.510539,"marketCap":192769403},{"date":"2023-04-14","current":-5.232327,"twenty":-5.29765,"median":-3.393436,"eighty":-1.509183,"marketCap":199613288},{"date":"2023-04-21","current":-5.501418,"twenty":-5.289761,"median":-3.393436,"eighty":-1.509183,"marketCap":209879114},{"date":"2023-04-28","current":-5.561216,"twenty":-5.289761,"median":-3.393436,"eighty":-1.509183,"marketCap":212160408},{"date":"2023-05-05","current":-5.680813,"twenty":-5.289761,"median":-3.393436,"eighty":-1.509183,"marketCap":216722998},{"date":"2023-05-12","current":-5.800409,"twenty":-5.289761,"median":-3.393436,"eighty":-1.509183,"marketCap":221285587},{"date":"2023-05-19","current":-7.226612,"twenty":-5.289761,"median":-3.393436,"eighty":-1.509183,"marketCap":292005724},{"date":"2023-05-26","current":-7.283156,"twenty":-5.344179,"median":-3.393436,"eighty":-1.509183,"marketCap":294290486},{"date":"2023-06-02","current":-8.271181,"twenty":-5.344179,"median":-3.393436,"eighty":-1.509183,"marketCap":334213614},{"date":"2023-06-09","current":-8.32764,"twenty":-5.344179,"median":-3.393436,"eighty":-1.509183,"marketCap":336494936},{"date":"2023-06-16","current":-8.976913,"twenty":-5.344179,"median":-3.393436,"eighty":-1.509183,"marketCap":362730134},{"date":"2023-06-23","current":-8.242952,"twenty":-5.335182,"median":-3.393436,"eighty":-1.507826,"marketCap":333072953},{"date":"2023-06-30","current":-7.621907,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":307978416},{"date":"2023-07-07","current":-8.497015,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":343338900},{"date":"2023-07-14","current":-9.132174,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":369003768},{"date":"2023-07-21","current":-11.632389,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":470029958},{"date":"2023-07-28","current":-10.963861,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":443016742},{"date":"2023-08-04","current":-11.933227,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":482185905},{"date":"2023-08-11","current":-12.1601,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":519066013},{"date":"2023-08-18","current":-10.893423,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":464996637},{"date":"2023-08-25","current":-11.590095,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":494734794},{"date":"2023-09-01","current":-11.463427,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":489327856},{"date":"2023-09-08","current":-12.033432,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":513659075},{"date":"2023-09-15","current":-11.653429,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":497438262},{"date":"2023-09-22","current":-12.1601,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":519066013},{"date":"2023-09-29","current":-11.970098,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":510955606},{"date":"2023-10-06","current":-11.938431,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":509603872},{"date":"2023-10-13","current":-10.355085,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":442017152},{"date":"2023-10-20","current":-10.101749,"twenty":-5.324018,"median":-3.393436,"eighty":-1.50647,"marketCap":431203276},{"date":"2023-10-27","current":-11.115091,"twenty":-5.29189,"median":-3.381076,"eighty":-1.505113,"marketCap":474458777},{"date":"2023-11-03","current":-11.400093,"twenty":-5.29189,"median":-3.381076,"eighty":-1.505113,"marketCap":486624387},{"date":"2023-11-10","current":-9.426398,"twenty":-5.29189,"median":-3.381076,"eighty":-1.505113,"marketCap":460941433},{"date":"2023-11-17","current":-9.977799,"twenty":-5.29189,"median":-3.381076,"eighty":-1.505113,"marketCap":487904391},{"date":"2023-11-24","current":-10.517513,"twenty":-5.313191,"median":-3.381076,"eighty":-1.505113,"marketCap":514295891},{"date":"2023-12-01","current":-10.655902,"twenty":-5.338428,"median":-3.381076,"eighty":-1.505113,"marketCap":521062942},{"date":"2023-12-08","current":-11.126422,"twenty":-5.415071,"median":-3.393436,"eighty":-1.505113,"marketCap":544070916},{"date":"2023-12-15","current":-12.316562,"twenty":-5.475519,"median":-3.393436,"eighty":-1.505113,"marketCap":602267556},{"date":"2023-12-22","current":-12.980826,"twenty":-5.561216,"median":-3.393436,"eighty":-1.505113,"marketCap":634749402},{"date":"2023-12-29","current":-13.340635,"twenty":-5.590213,"median":-3.381076,"eighty":-1.505113,"marketCap":652343735},{"date":"2024-01-05","current":-12.039785,"twenty":-5.620881,"median":-3.368717,"eighty":-1.505113,"marketCap":588733454},{"date":"2024-01-12","current":-11.596942,"twenty":-5.710712,"median":-3.368717,"eighty":-1.505113,"marketCap":567078890},{"date":"2024-01-19","current":-11.818364,"twenty":-5.829149,"median":-3.367888,"eighty":-1.505113,"marketCap":577906172},{"date":"2024-01-26","current":-13.783478,"twenty":-5.911883,"median":-3.368717,"eighty":-1.505113,"marketCap":673998299},{"date":"2024-02-02","current":-14.0049,"twenty":-6.006255,"median":-3.368717,"eighty":-1.505113,"marketCap":684825581},{"date":"2024-02-09","current":-13.202247,"twenty":-6.098621,"median":-3.368717,"eighty":-1.505113,"marketCap":645576684},{"date":"2024-02-16","current":-13.755801,"twenty":-6.227598,"median":-3.368717,"eighty":-1.505113,"marketCap":672644889},{"date":"2024-02-23","current":-13.589734,"twenty":-6.366195,"median":-3.368717,"eighty":-1.505113,"marketCap":664524427},{"date":"2024-03-01","current":-13.977222,"twenty":-6.479218,"median":-3.381076,"eighty":-1.505113,"marketCap":683472171},{"date":"2024-03-08","current":-13.831517,"twenty":-6.90205,"median":-3.381076,"eighty":-1.505113,"marketCap":756556324},{"date":"2024-03-15","current":-11.769541,"twenty":-7.041838,"median":-3.381076,"eighty":-1.505113,"marketCap":643770337},{"date":"2024-03-22","current":-12.350441,"twenty":-7.184539,"median":-3.381076,"eighty":-1.505113,"marketCap":675544409},{"date":"2024-03-28","current":-12.249415,"twenty":-7.248225,"median":-3.381076,"eighty":-1.505113,"marketCap":670018483},{"date":"2024-04-05","current":-11.643258,"twenty":-7.32724,"median":-3.368717,"eighty":-1.505113,"marketCap":636862930},{"date":"2024-04-12","current":-13.486984,"twenty":-7.368011,"median":-3.368717,"eighty":-1.505113,"marketCap":737711072},{"date":"2024-04-19","current":-12.100371,"twenty":-7.497698,"median":-3.368717,"eighty":-1.505113,"marketCap":661866110},{"date":"2024-04-26","current":-11.241472,"twenty":-7.68836,"median":-3.381076,"eighty":-1.505113,"marketCap":614886052},{"date":"2024-05-03","current":-11.822492,"twenty":-7.80485,"median":-3.381076,"eighty":-1.505113,"marketCap":646666679},{"date":"2024-05-10","current":-10.864479,"twenty":-8.073576,"median":-3.381076,"eighty":-1.505113,"marketCap":700617677},{"date":"2024-05-17","current":-10.114466,"twenty":-8.073576,"median":-3.381076,"eighty":-1.505113,"marketCap":652251565},{"date":"2024-05-24","current":-8.935874,"twenty":-8.073576,"median":-3.381076,"eighty":-1.505113,"marketCap":576247675},{"date":"2024-05-31","current":-8.8073,"twenty":-8.073576,"median":-3.381076,"eighty":-1.505113,"marketCap":567956342},{"date":"2024-06-07","current":-8.614439,"twenty":-8.073576,"median":-3.381076,"eighty":-1.505113,"marketCap":555519341},{"date":"2024-06-14","current":-8.700155,"twenty":-8.073576,"median":-3.393436,"eighty":-1.505113,"marketCap":561046897},{"date":"2024-06-21","current":-7.971571,"twenty":-8.211511,"median":-3.393487,"eighty":-1.505113,"marketCap":514062674},{"date":"2024-06-28","current":-8.164431,"twenty":-8.254244,"median":-3.407341,"eighty":-1.505113,"marketCap":526499674},{"date":"2024-07-05","current":-11.041081,"twenty":-8.350223,"median":-3.420082,"eighty":-1.505113,"marketCap":712006195},{"date":"2024-07-12","current":-12.928009,"twenty":-8.542182,"median":-3.422439,"eighty":-1.505113,"marketCap":833688547},{"date":"2024-07-15","current":-12.469027,"twenty":-8.611735,"median":-3.435172,"eighty":-1.505113,"marketCap":804090137},{"date":"2024-08-02","current":-11.576561,"twenty":-8.657297,"median":-3.483445,"eighty":-1.495778,"marketCap":746537673},{"date":"2024-08-09","current":-10.327108,"twenty":-8.743013,"median":-3.517337,"eighty":-1.495778,"marketCap":665964224},{"date":"2024-08-16","current":-9.860251,"twenty":-8.835767,"median":-3.540281,"eighty":-1.495778,"marketCap":742348719},{"date":"2024-08-23","current":-9.64162,"twenty":-8.935874,"median":-3.567458,"eighty":-1.495778,"marketCap":725888659},{"date":"2024-08-30","current":-9.226222,"twenty":-8.976913,"median":-3.594054,"eighty":-1.495778,"marketCap":694614544},{"date":"2024-09-06","current":-9.92584,"twenty":-9.085876,"median":-3.621282,"eighty":-1.495778,"marketCap":747286737},{"date":"2024-09-13","current":-9.269948,"twenty":-9.204358,"median":-3.662907,"eighty":-1.495778,"marketCap":697906556},{"date":"2024-09-20","current":-10.144471,"twenty":-9.278737,"median":-3.69958,"eighty":-1.495778,"marketCap":763746797},{"date":"2024-09-27","current":-9.269948,"twenty":-9.335537,"median":-3.746155,"eighty":-1.495778,"marketCap":697906556},{"date":"2024-10-04","current":-8.329835,"twenty":-9.335537,"median":-3.778343,"eighty":-1.505113,"marketCap":627128297},{"date":"2024-10-11","current":-7.87071,"twenty":-9.335537,"median":-3.801653,"eighty":-1.528294,"marketCap":592562170},{"date":"2024-10-18","current":-7.980026,"twenty":-9.335537,"median":-3.834375,"eighty":-1.549946,"marketCap":600792200},{"date":"2024-10-25","current":-7.30227,"twenty":-9.335537,"median":-3.860545,"eighty":-1.556351,"marketCap":549766014},{"date":"2024-10-31","current":-7.958163,"twenty":-9.335537,"median":-3.893503,"eighty":-1.562755,"marketCap":599146194},{"date":"2024-11-08","current":-8.78896,"twenty":-9.353709,"median":-3.91265,"eighty":-1.576715,"marketCap":661694424},{"date":"2024-11-15","current":-6.601047,"twenty":-9.353709,"median":-3.968149,"eighty":-1.588088,"marketCap":547464431},{"date":"2024-11-22","current":-6.704512,"twenty":-9.353709,"median":-4.002514,"eighty":-1.599903,"marketCap":556045378},{"date":"2024-11-29","current":-6.952827,"twenty":-9.353709,"median":-4.031518,"eighty":-1.612485,"marketCap":576639651},{"date":"2024-12-06","current":-7.449457,"twenty":-9.353709,"median":-4.06865,"eighty":-1.643185,"marketCap":617828198},{"date":"2024-12-13","current":-6.932134,"twenty":-9.353709,"median":-4.119828,"eighty":-1.655744,"marketCap":574923462},{"date":"2024-12-20","current":-8.157595,"twenty":-9.353709,"median":-4.147533,"eighty":-1.664831,"marketCap":676558329},{"date":"2024-12-27","current":-8.283874,"twenty":-9.353709,"median":-4.176536,"eighty":-1.687705,"marketCap":687031368},{"date":"2025-01-03","current":-7.753504,"twenty":-9.353709,"median":-4.193651,"eighty":-1.695455,"marketCap":643044603},{"date":"2025-01-10","current":-7.677737,"twenty":-9.371881,"median":-4.217893,"eighty":-1.693654,"marketCap":636760780},{"date":"2025-01-17","current":-7.349413,"twenty":-9.371881,"median":-4.24322,"eighty":-1.693654,"marketCap":609530878},{"date":"2025-01-24","current":-7.273645,"twenty":-9.371881,"median":-4.263547,"eighty":-1.693654,"marketCap":603247055},{"date":"2025-01-31","current":-7.0716,"twenty":-9.371881,"median":-4.295751,"eighty":-1.693654,"marketCap":586490192},{"date":"2025-02-07","current":-7.172623,"twenty":-9.371881,"median":-4.324072,"eighty":-1.708924,"marketCap":594868623},{"date":"2025-02-14","current":-7.147367,"twenty":-9.371881,"median":-4.350344,"eighty":-1.740807,"marketCap":592774015},{"date":"2025-02-21","current":-6.793787,"twenty":-9.371881,"median":-4.368299,"eighty":-1.740807,"marketCap":563449506},{"date":"2025-02-28","current":-6.212905,"twenty":-9.371881,"median":-4.377594,"eighty":-1.761302,"marketCap":515273526},{"date":"2025-03-07","current":-6.566485,"twenty":-9.390054,"median":-4.397509,"eighty":-1.766426,"marketCap":544598035},{"date":"2025-03-14","current":-6.970577,"twenty":-9.390054,"median":-4.426631,"eighty":-1.849687,"marketCap":578111761},{"date":"2025-03-21","current":-7.223134,"twenty":-9.390054,"median":-4.455754,"eighty":-2.630922,"marketCap":599057839},{"date":"2025-03-28","current":-6.073163,"twenty":-9.390054,"median":-4.529252,"eighty":-2.706091,"marketCap":582300976},{"date":"2025-04-04","current":-6.365989,"twenty":-9.390054,"median":-4.555508,"eighty":-2.731148,"marketCap":610377439},{"date":"2025-04-11","current":-5.795246,"twenty":-9.371881,"median":-4.597373,"eighty":-2.756204,"marketCap":555653944},{"date":"2025-04-17","current":-6.431845,"twenty":-9.371881,"median":-4.606018,"eighty":-2.78126,"marketCap":616691688},{"date":"2025-04-25","current":-7.178202,"twenty":-9.390054,"median":-4.631607,"eighty":-2.806317,"marketCap":688253181},{"date":"2025-05-02","current":-7.15625,"twenty":-9.390054,"median":-4.638411,"eighty":-2.831373,"marketCap":686148431},{"date":"2025-05-09","current":-7.072289,"twenty":-9.390054,"median":-4.657196,"eighty":-2.85643,"marketCap":678098122},{"date":"2025-05-16","current":-6.413042,"twenty":-9.390054,"median":-4.661881,"eighty":-2.873318,"marketCap":655246189},{"date":"2025-05-23","current":-6.041869,"twenty":-9.390054,"median":-4.688734,"eighty":-2.888127,"marketCap":617321972},{"date":"2025-05-30","current":-4.61904,"twenty":-9.390054,"median":-4.689631,"eighty":-2.910465,"marketCap":471945808},{"date":"2025-06-06","current":-4.90773,"twenty":-9.390054,"median":-4.717857,"eighty":-2.931599,"marketCap":501442421},{"date":"2025-06-13","current":-4.660282,"twenty":-9.390054,"median":-4.745129,"eighty":-2.956655,"marketCap":476159610},{"date":"2025-06-20","current":-4.268488,"twenty":-9.408226,"median":-4.745129,"eighty":-2.972398,"marketCap":436128492},{"date":"2025-06-27","current":-4.557178,"twenty":-9.408226,"median":-4.745129,"eighty":-2.997168,"marketCap":465625105},{"date":"2025-07-03","current":-4.515937,"twenty":-9.408226,"median":-4.745129,"eighty":-3.006768,"marketCap":461411303},{"date":"2025-07-11","current":-4.742764,"twenty":-9.408226,"median":-4.751796,"eighty":-3.031824,"marketCap":484587213},{"date":"2025-07-18","current":-4.825247,"twenty":-9.408226,"median":-4.769744,"eighty":-3.056881,"marketCap":493014817},{"date":"2025-07-25","current":-5.258282,"twenty":-9.408226,"median":-4.785378,"eighty":-3.076726,"marketCap":537259737},{"date":"2025-08-01","current":-5.340765,"twenty":-9.408226,"median":-4.825247,"eighty":-3.084799,"marketCap":545687340},{"date":"2025-08-08","current":-5.423248,"twenty":-9.408226,"median":-4.864376,"eighty":-3.106994,"marketCap":554114944},{"date":"2025-08-15","current":-5.747899,"twenty":-9.408226,"median":-4.911625,"eighty":-3.127725,"marketCap":634177179},{"date":"2025-08-22","current":-5.824283,"twenty":-9.408226,"median":-4.939374,"eighty":-3.147266,"marketCap":642604783},{"date":"2025-08-29","current":-6.244395,"twenty":-9.408226,"median":-4.968358,"eighty":-3.163746,"marketCap":688956604},{"date":"2025-09-05","current":-6.836371,"twenty":-9.426398,"median":-5.052933,"eighty":-3.178816,"marketCap":754270532},{"date":"2025-09-12","current":-6.855467,"twenty":-9.408226,"median":-5.072724,"eighty":-3.195327,"marketCap":756377433},{"date":"2025-09-19","current":-6.874563,"twenty":-9.408226,"median":-5.134558,"eighty":-3.195327,"marketCap":758484334},{"date":"2025-09-26","current":-6.626315,"twenty":-9.408226,"median":-5.15883,"eighty":-3.205742,"marketCap":731094622},{"date":"2025-10-03","current":-6.664507,"twenty":-9.408226,"median":-5.198379,"eighty":-3.220097,"marketCap":735308424},{"date":"2025-10-10","current":-6.530835,"twenty":-9.408226,"median":-5.24421,"eighty":-3.232276,"marketCap":720560118},{"date":"2025-10-17","current":-6.836371,"twenty":-9.408226,"median":-5.289213,"eighty":-3.245577,"marketCap":754270532},{"date":"2025-10-24","current":-7.867556,"twenty":-9.408226,"median":-5.346344,"eighty":-3.257332,"marketCap":868043183},{"date":"2025-10-31","current":-8.211284,"twenty":-9.408226,"median":-5.417485,"eighty":-3.269637,"marketCap":905967399},{"date":"2025-11-07","current":-8.627061,"twenty":-9.408226,"median":-5.493264,"eighty":-3.282388,"marketCap":951840860},{"date":"2025-11-14","current":-9.317583,"twenty":-9.418263,"median":-5.561814,"eighty":-3.307084,"marketCap":1028027528},{"date":"2025-11-21","current":-9.745075,"twenty":-9.444852,"median":-5.606096,"eighty":-3.315062,"marketCap":1126969144},{"date":"2025-11-28","current":-13.125593,"twenty":-9.545423,"median":-5.665864,"eighty":-3.336451,"marketCap":1517909190},{"date":"2025-12-05","current":-13.292532,"twenty":-9.616636,"median":-5.72393,"eighty":-3.357699,"marketCap":1537214871},{"date":"2025-12-12","current":-14.481974,"twenty":-9.680973,"median":-5.814735,"eighty":-3.36739,"marketCap":1674767851},{"date":"2025-12-19","current":-12.645643,"twenty":-9.812152,"median":-5.830308,"eighty":-3.393446,"marketCap":1462405356},{"date":"2025-12-26","current":-13.355134,"twenty":-9.912722,"median":-5.859766,"eighty":-3.396324,"marketCap":1544454502},{"date":"2026-01-02","current":-12.583041,"twenty":-10.058665,"median":-5.911883,"eighty":-3.418622,"marketCap":1455165726},{"date":"2026-01-09","current":-12.019621,"twenty":-10.141582,"median":-5.999939,"eighty":-3.422439,"marketCap":1390009052},{"date":"2026-01-16","current":-12.27003,"twenty":-10.265424,"median":-6.039292,"eighty":-3.450393,"marketCap":1418967574},{"date":"2026-01-23","current":-13.480339,"twenty":-10.320481,"median":-6.082171,"eighty":-3.481646,"marketCap":1558933763},{"date":"2026-01-30","current":-11.644008,"twenty":-10.355085,"median":-6.120046,"eighty":-3.517337,"marketCap":1346571269},{"date":"2026-02-06","current":-11.024995,"twenty":-10.513189,"median":-6.1897,"eighty":-3.539185,"marketCap":1274985540},{"date":"2026-02-13","current":-12.456535,"twenty":-10.658057,"median":-6.270837,"eighty":-3.567458,"marketCap":1440535988},{"date":"2026-02-20","current":-12.221506,"twenty":-10.788754,"median":-6.304726,"eighty":-3.59261,"marketCap":1413356064}],"updateTime":1771799457590},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SVRA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2613521367","title":"Stocks to Watch: iPower, Savara","url":"https://stock-news.laohu8.com/highlight/detail?id=2613521367","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613521367?lang=en_us&edition=fundamental","pubTime":"2026-02-21 07:30","pubTimestamp":1771630200,"startTime":"0","endTime":"0","summary":"iPower said it restructured its supply chain to consolidate vendors and shift toward U.S.-based sourcing. Shares rallied 5% to $3.42 after closing down 3.3% on Friday.Savara received priority review from the Food and Drug Administration for its application for Molbreevi. The stock rose 3.6% after closing down 3.3%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IPW","SVRA","BK4122","BK4539","BK4104"],"gpt_icon":0},{"id":"2613829031","title":"Savara Inc. Publishes Corporate Presentation on Autoimmune PAP and MOLBREEVI (Molgramostim) Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2613829031","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613829031?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:42","pubTimestamp":1771623745,"startTime":"0","endTime":"0","summary":"Savara Inc. released a corporate presentation highlighting its focus on autoimmune pulmonary alveolar proteinosis , a rare chronic lung disease caused by GM-CSF autoantibodies that impair surfactant clearance and can lead to hypoxemic respiratory failure. The company outlines that there are no approved drugs in the U.S. or Europe for autoimmune PAP and that whole lung lavage remains an invasive, non-standardized treatment that may need to be repeated. The presentation includes an overview of MOLBREEVI , an investigational drug-device product administered once daily via a proprietary eFlow nebulizer system. Savara summarizes Phase 3 IMPALA-2 data showing improvements versus placebo in the primary endpoint of change from baseline in DLCO% at Week 24  and a secondary endpoint at Week 48 , along with reported changes in patient-reported outcomes and exercise capacity measures. Savara also notes that the FDA accepted its BLA for filing. You can access the full presentation through the link ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDLbV4l5r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2613529765","title":"FDA accepts Savara’s MOLBREEVI BLA for priority review in autoimmune PAP","url":"https://stock-news.laohu8.com/highlight/detail?id=2613529765","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613529765?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:15","pubTimestamp":1771622123,"startTime":"0","endTime":"0","summary":"Savara Inc. said the U.S. Food and Drug Administration has filed for review its Biologics License Application for MOLBREEVI to treat autoimmune pulmonary alveolar proteinosis. The FDA granted Priority Review and set a PDUFA action date of August 22, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Savara Inc. published the original content used to generate this news brief via Business Wire  on February 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL9HMwcx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2613503297","title":"Savara Inc - to Submit Molbreevi MAAS to Ema and Mhra by Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2613503297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613503297?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:15","pubTimestamp":1771622100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nTUA4FSKXR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2613297540","title":"Savara Announces the U.S. Food and Drug Administration (FDA) Filed the Molbreevi* Biologics License Application (Bla) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune Pap)","url":"https://stock-news.laohu8.com/highlight/detail?id=2613297540","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613297540?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:15","pubTimestamp":1771622100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nTUA4FSKXR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2613297506","title":"Savara Inc - FDA Grants Priority Review, Pdufa Date August 22, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2613297506","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613297506?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:15","pubTimestamp":1771622100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nTUA4FSKXR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2612413291","title":"A Look At Savara (SVRA) Valuation After Recent FDA Progress And Strengthened Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2612413291","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612413291?lang=en_us&edition=fundamental","pubTime":"2026-02-18 13:28","pubTimestamp":1771392501,"startTime":"0","endTime":"0","summary":"Why Savara’s recent FDA progress is back in focus\nSavara (SVRA) is back on investor radars after resubmitting its biologics license application, completing a tech transfer to Fujifilm, and aligning key analytical protocols with the FDA.\nWith an FDA filing decision expected in the near term and management expressing strong confidence in the updated package, the upcoming Guggenheim Securities Emerging Outlook, Biotech Summit presentation on February 11 is drawing extra attention from...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara/news/a-look-at-savara-svra-valuation-after-recent-fda-progress-an","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara/news/a-look-at-savara-svra-valuation-after-recent-fda-progress-an","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065732104.USD","BK4097","SVRA","BK4139","PRGS"],"gpt_icon":0},{"id":"2611198777","title":"Savara Inc. Grants Equity Awards to New Employee","url":"https://stock-news.laohu8.com/highlight/detail?id=2611198777","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611198777?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:05","pubTimestamp":1771016718,"startTime":"0","endTime":"0","summary":"Savara Inc. has granted inducement awards to a new employee, consisting of options to purchase 7,500 shares of common stock at an exercise price of $5.27 per share and restricted stock units  for 7,500 shares. The stock options have a 10-year term and vest in equal installments quarterly over four years. The RSUs vest in full on the two-year anniversary of the employee’s start date, contingent on continued employment.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL3lBVfp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2609927318","title":"Savara Inc. nimmt an bevorstehenden Investor Healthcare Conferences teil","url":"https://stock-news.laohu8.com/highlight/detail?id=2609927318","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609927318?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:05","pubTimestamp":1770239132,"startTime":"0","endTime":"0","summary":"Savara Inc. wird am 11. Februar am Guggenheim Emerging Outlook: Biotech Summit sowie am 25. Februar an der Oppenheimer 36th Annual Healthcare Life Sciences Conference teilnehmen.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Savara Inc. published the original content used to generate this news brief via Business Wire  on February 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL7j2Rz1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2607230721","title":"Savara Inc. Highlights Leadership Team and Progress on MOLBREEVI for Autoimmune PAP in New Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2607230721","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607230721?lang=en_us&edition=fundamental","pubTime":"2026-01-29 07:42","pubTimestamp":1769643750,"startTime":"0","endTime":"0","summary":"Savara Inc. has released a corporate presentation highlighting recent developments in its executive leadership team and clinical programs. The presentation provides an overview of the company’s senior management, including CEO Matthew Pauls, Chief Medical Officer Yasmine Wasfi, and other key executives. A focal point of the presentation is MOLBREEVI , which has shown clinically meaningful positive Phase 3 results in the treatment of autoimmune pulmonary alveolar proteinosis . The data suggest that MOLBREEVI may address the underlying pathophysiology of autoimmune PAP, with a favorable benefit/risk profile and good tolerability. A Biologics License Application  for MOLBREEVI was submitted to the FDA in December 2025. The presentation also details the disease burden faced by autoimmune PAP patients, emphasizing the impact on quality of life and increased healthcare utilization compared to matched controls. Patient experiences, including diagnostic challenges and treatment journeys, are a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL3LHLJ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2606731331","title":"Savara Secures Up to $75 Million in Additional Debt Funding from Hercules Capital Pending FDA Approval of MOLBREEVI","url":"https://stock-news.laohu8.com/highlight/detail?id=2606731331","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606731331?lang=en_us&edition=fundamental","pubTime":"2026-01-28 01:22","pubTimestamp":1769534567,"startTime":"0","endTime":"0","summary":"Savara Inc., a clinical-stage biopharmaceutical company focused on rare respiratory diseases, has amended its loan and security agreement with Hercules Capital, Inc. Under the revised terms, Savara will gain access to up to an additional $75 million in debt funding upon FDA approval of its investigational therapy MOLBREEVI for autoimmune pulmonary alveolar proteinosis . This amendment strengthens Savara’s balance sheet and liquidity as it prepares for a potential product launch. The agreement maintains the original maturity date and interest-only period, and does not include any warrants. Combined with a previously announced $75 million royalty funding agreement with RTW, Savara expects to have approximately $150 million in non-dilutive capital available to support MOLBREEVI’s launch activities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL6z6r7Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4135","BK4139","HTGC"],"gpt_icon":0},{"id":"2606784252","title":"Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of Molbreevi*","url":"https://stock-news.laohu8.com/highlight/detail?id=2606784252","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606784252?lang=en_us&edition=fundamental","pubTime":"2026-01-27 21:05","pubTimestamp":1769519100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nTUA85MGKC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2606647672","title":"Assessing Savara (SVRA) Valuation As Legal Scrutiny Over MOLBREEVI Disclosures Intensifies","url":"https://stock-news.laohu8.com/highlight/detail?id=2606647672","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606647672?lang=en_us&edition=fundamental","pubTime":"2026-01-26 07:15","pubTimestamp":1769382921,"startTime":"0","endTime":"0","summary":"Why the Savara (SVRA) story is back in focus\nThe latest headline around Savara (SVRA) centers on a law firm investigation into potential fiduciary duty breaches, following a class action tied to the FDA’s refusal of the company’s MOLBREEVI Biologics License Application.\nSee our latest analysis for Savara.\nThe legal scrutiny arrives after a sharp reaction to the FDA’s MOLBREEVI decision. At the same time, the stock’s 90 day share price return of 37.44% and 1 year total shareholder return of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara/news/assessing-savara-svra-valuation-as-legal-scrutiny-over-molbr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara/news/assessing-savara-svra-valuation-as-legal-scrutiny-over-molbr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2604157147","title":"DIARY-India economic, corporate events on January 20","url":"https://stock-news.laohu8.com/highlight/detail?id=2604157147","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604157147?lang=en_us&edition=fundamental","pubTime":"2026-01-20 10:00","pubTimestamp":1768874400,"startTime":"0","endTime":"0","summary":"DIARY-India economic, corporate events on January 20BENGALURU, Jan 20 (Reuters) - Diary of India economic, corporate events on January 20.    ECONOMIC, CORPORATE .BSE500 EVENTS:Start DateStart TimeRIC","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4N3YK0YT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1718418525.SGD","DGE.UK","LU0738911758.USD","SG9999003800.SGD","SG9999011175.SGD","SG9999004303.SGD","LU0949170772.SGD","LU1829250122.USD","BK5112","LU1064927863.SGD","SGXZ23171101.USD","LU0661504455.SGD","SVRA"],"gpt_icon":0},{"id":"2604919665","title":"Savara Grants Stock Options and RSUs to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2604919665","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604919665?lang=en_us&edition=fundamental","pubTime":"2026-01-17 05:05","pubTimestamp":1768597519,"startTime":"0","endTime":"0","summary":"Savara Inc. has granted inducement awards to two new employees, including options to purchase a total of 17,500 shares of common stock at an exercise price of $5.88 per share and restricted stock units  covering 12,500 shares. The stock options have a 10-year term and vest in equal installments every quarter over four years. The RSUs will vest in full on the second anniversary of each employee’s start date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Savara Inc. published the original content used to generate this news brief via Business Wire  on January 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nNDL4X6DhM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2604622911","title":"What Savara (SVRA)'s Exclusive PANTHERx MOLBREEVI Distribution Deal Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2604622911","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604622911?lang=en_us&edition=fundamental","pubTime":"2026-01-17 04:12","pubTimestamp":1768594367,"startTime":"0","endTime":"0","summary":"PANTHERx Rare Pharmacy and Savara Inc. recently announced an exclusive U.S. distribution agreement for MOLBREEVI, following Savara’s December 2025 Biologics License Application submission to the FDA for treating autoimmune PAP with a Priority Review request.\nThis tie-up with a rare-disease focused pharmacy positions Savara with a specialized channel for potential commercialization, including clinical support, education, and financial assistance for patients and prescribers.\nWe’ll now examine...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara/news/what-savara-svras-exclusive-pantherx-molbreevi-distribution","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara/news/what-savara-svras-exclusive-pantherx-molbreevi-distribution","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2602305109","title":"Savara (SVRA): Advancing MOLBREEVI Toward Likely FDA Approval and Blockbuster Rare Disease Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2602305109","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602305109?lang=en_us&edition=fundamental","pubTime":"2026-01-10 02:56","pubTimestamp":1767984971,"startTime":"0","endTime":"0","summary":"Savara, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Francois Brisebois from LifeSci Capital maintained a B...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/savara-svra-advancing-molbreevi-toward-likely-fda-approval-and-blockbuster-rare-disease-potential-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/savara-svra-advancing-molbreevi-toward-likely-fda-approval-and-blockbuster-rare-disease-potential-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4585","BK4588","SVRA","BK4581","BK4139","XLV","LABU"],"gpt_icon":0},{"id":"2602602318","title":"Savara Submits MOLBREEVI BLA to FDA for Autoimmune PAP Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2602602318","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602602318?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:05","pubTimestamp":1767906349,"startTime":"0","endTime":"0","summary":"Savara Inc. has submitted a Biologics License Application  for MOLBREEVI to the U.S. Food and Drug Administration  in December 2025, seeking approval for the treatment of autoimmune pulmonary alveolar proteinosis . The company has requested Priority Review for the investigational inhaled therapy. If approved, PANTHERx Rare Pharmacy will serve as the exclusive U.S. specialty pharmacy for MOLBREEVI, providing specialized distribution and patient support services.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Savara Inc. published the original content used to generate this news brief via Business Wire  on January 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL3b6mcC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2593948434","title":"Savara Inc : H.c. Wainwright Raises Target Price to $10","url":"https://stock-news.laohu8.com/highlight/detail?id=2593948434","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593948434?lang=en_us&edition=fundamental","pubTime":"2025-12-23 19:08","pubTimestamp":1766488137,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nFWN3XT0BF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SVRA"],"gpt_icon":0},{"id":"2593493768","title":"How Investors May Respond To Savara (SVRA) Joining S&P Biotech Index After Key MOLBREEVI Patent Win","url":"https://stock-news.laohu8.com/highlight/detail?id=2593493768","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593493768?lang=en_us&edition=fundamental","pubTime":"2025-12-23 13:15","pubTimestamp":1766466901,"startTime":"0","endTime":"0","summary":"In December 2025, Savara Inc. was added to the S&P Biotechnology Select Industry Index after the European Patent Office signaled its intention to grant patent protection for the liquid formulation of MOLBREEVI, an inhaled GM-CSF therapy for autoimmune PAP. \nThis combination of index inclusion and advancing intellectual property around a Fast Track- and Breakthrough Therapy-designated rare-disease candidate highlights growing recognition of Savara’s specialist respiratory focus. \nWe’ll...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara/news/how-investors-may-respond-to-savara-svra-joining-sp-biotech","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara/news/how-investors-may-respond-to-savara-svra-joining-sp-biotech","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","SVRA","BK4139","BK4211"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":75,"code":"91000000","status":"200"}]}}